The current valuation score of Arbutus Biopharma Corp is 8.58, ranking 113 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is 5.34, which is 4.74% below the recent high of 5.59 and 605.48% above the recent low of -26.99.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.